Page last updated: 2024-12-07

neo-kyotorphin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Neo-kyotorphin is a synthetic opioid peptide with the sequence Tyr-Arg-Phe-Lys-NH2. It was first synthesized in 1983 and has been shown to have analgesic effects in animal models. Neo-kyotorphin is a selective agonist of the delta opioid receptor, and its effects are mediated by the activation of this receptor. It is known to exhibit analgesic effects comparable to morphine in animal models, suggesting potential therapeutic value for pain management. The compound is also studied for its potential in treating other conditions like depression and anxiety due to its ability to interact with the opioid system, which plays a role in mood regulation. Research on neo-kyotorphin focuses on understanding its mechanisms of action and potential therapeutic applications. '

neo-kyotorphin: isolated from bovine brain; opioid peptide [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID122173
MeSH IDM0111035

Synonyms (17)

Synonym
tskyr peptide
d-sero-2-nkt
neokyotorphin
thr-ser-lys-tyr-arg
l-arginine, n2-(n-(n2-(n-l-threonyl-l-seryl)-l-lysyl)-l-tyrosyl)-
threonyl-seryl-lysyl-tyrosyl-arginine
neo-kyotorphin
83759-54-0
(2s)-2-[[(2s)-2-[[(2s)-6-amino-2-[[(2s)-2-[[(2s,3r)-2-amino-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]hexanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid
unii-5etk5e501l
5etk5e501l ,
neokiotorphin
l-arginine, l-threonyl-l-seryl-l-lysyl-l-tyrosyl-
h-thr-ser-lys-tyr-arg-oh
Q27261937
n~2~-[2-{[6-amino-2-({2-[(2-amino-1,3-dihydroxybutylidene)amino]-1,3-dihydroxypropylidene}amino)-1-hydroxyhexylidene]amino}-1-hydroxy-3-(4-hydroxyphenyl)propylidene]arginine
DTXSID401003796
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (29)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (27.59)18.7374
1990's13 (44.83)18.2507
2000's8 (27.59)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.66

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.66 (24.57)
Research Supply Index3.74 (2.92)
Research Growth Index4.40 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.66)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (4.88%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other39 (95.12%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]